Home > Boards > US Listed > Biotechs > Contrafect Corp (CFRX)

Bought some at 58 cents.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
willlbone Member Profile
 
Followed By 72
Posts 5,849
Boards Moderated 0
Alias Born 06/28/07
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 3/18/2020 5:04:23 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/18/2020 4:59:18 PM
ContraFect Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update GlobeNewswire Inc. - 3/18/2020 7:00:10 AM
ContraFect to Present at FDA Workshop on Advancing Animal Models for Antibacterial Drug Development GlobeNewswire Inc. - 3/4/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/24/2020 6:15:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/24/2020 4:59:13 PM
ContraFect Announces U.S. FDA Grants Breakthrough Therapy Designation to Exebacase for the Treatment of Methicillin-Resistant... GlobeNewswire Inc. - 2/24/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 5:18:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 5:16:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 5:13:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 5:09:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/21/2020 5:03:16 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:47:19 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:30:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 4:33:44 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2020 6:04:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/4/2020 7:04:12 AM
ContraFect Announces One-for-Ten Reverse Stock Split GlobeNewswire Inc. - 2/4/2020 7:00:10 AM
ContraFect Appoints Jane E. Ambler, Ph.D. as Vice President of Clinical Microbiology GlobeNewswire Inc. - 2/3/2020 7:00:10 AM
ContraFect Announces Oral Presentations at the 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMI... GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
ContraFect to Present at 2020 ASM Biothreats GlobeNewswire Inc. - 1/22/2020 7:00:10 AM
ContraFect Partners with Leading Orthopedic Center in Europe to Provide Compassionate Use of Exebacase to Patients with Chron... GlobeNewswire Inc. - 1/13/2020 8:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/10/2020 12:53:39 PM
ContraFect Announces First Patient Dosed in Pivotal Phase 3 DISRUPT Study of Exebacase as a Treatment for Staph aureus Bacter... GlobeNewswire Inc. - 1/10/2020 7:00:10 AM
ContraFect to Present at Biotech Showcase 2020 GlobeNewswire Inc. - 1/6/2020 5:30:10 PM
willlbone   Saturday, 01/12/19 09:38:42 AM
Re: PennyStock Alert post# 87
Post # of 229 
Bought some at 58 cents.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist